Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04220398
What this trial is testing

Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

Who this might be right for
Prostate CancerChemotherapy EffectHormone Sensitive Prostate Cancer+1 more
RenJi Hospital 475
Early research (Phase 1)Active Not RecruitingNCT06229366
What this trial is testing

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerOligometastatic Prostate Carcinoma+1 more
Eli Lilly and Company 142
Testing effectiveness (Phase 2)Study completedNCT01503229
What this trial is testing

Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
University of Washington 32
Not applicableUnknownNCT00345072
What this trial is testing

A Menopause Interactive Decision Aid System

Who this might be right for
Menopause
Rhode Island Hospital 296
Large-scale testing (Phase 3)UnknownNCT03119857
What this trial is testing

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Who this might be right for
Prostatic Neoplasms
Göteborg University 349
Not applicableStudy completedNCT02015273
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 82
Not applicableUnknownNCT04852081
What this trial is testing

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Who this might be right for
Breast Cancer Stage IV
Blokhin's Russian Cancer Research Center 1,000
Early research (Phase 1)WithdrawnNCT01240928
What this trial is testing

MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Vanderbilt-Ingram Cancer Center
Large-scale testing (Phase 3)Study completedNCT00338312
What this trial is testing

Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Who this might be right for
Hypoactive Sexual Desire Disorder
Warner Chilcott 610
Not applicableStudy completedNCT00516698
What this trial is testing

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 140
Large-scale testing (Phase 3)Active Not RecruitingNCT04055493
What this trial is testing

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

Who this might be right for
Breast Cancer Female
Women's Cancer Study Group GmbH 1,684
Not applicableLooking for participantsNCT06106477
What this trial is testing

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 20
Not applicableStudy completedNCT06357130
What this trial is testing

Gynaecological Care for Transgender People in France in 2024.

Who this might be right for
Transgender Management Care
University Hospital, Bordeaux 246
Not applicableLooking for participantsNCT05280028
What this trial is testing

HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness

Who this might be right for
Menopausal Syndrome
Far Eastern Memorial Hospital 100
Not applicableEnded earlyNCT02677311
What this trial is testing

GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient

Who this might be right for
CancerChemoradiation
University of Kentucky 2
Testing effectiveness (Phase 2)Ended earlyNCT00556400
What this trial is testing

Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones

Who this might be right for
Aplastic AnemiaMenorrhagiaAmenorrhea
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1
Post-approval studies (Phase 4)Study completedNCT00929799
What this trial is testing

Growth Hormone and Glucose Metabolism

Who this might be right for
Growth Hormone Deficiency
Charite University, Berlin, Germany 6
Not applicableLooking for participantsNCT04794075
What this trial is testing

Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer

Who this might be right for
Neoplasm of Breast
Centre Hospitalier Emile Roux 300
Early research (Phase 1)Study completedNCT04346901
What this trial is testing

Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma

Who this might be right for
MelasmaHyperthyroidism
Dr.dr.Irma Bernadette, SpKK (K) 23
Large-scale testing (Phase 3)Study completedNCT01546987
What this trial is testing

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 239
Next Page